These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5403804)

  • 21. [The influence of twice-weekly hemodialytic treatment on the hypertensive syndrome in chronic uremic patients].
    Cioni L; Biagini M; Gloria E; Pentimone F
    Minerva Nefrol; 1966; 13(4):112-5. PubMed ID: 5995530
    [No Abstract]   [Full Text] [Related]  

  • 22. [HDL-cholesterol in chronic uremia during hemodialytic treatment].
    Solinas A; Demelia L; Cogoni G; Porcu A; Civolani P; Usai E; Pitzus F
    Minerva Nefrol; 1981; 28(4):455-60. PubMed ID: 7339513
    [No Abstract]   [Full Text] [Related]  

  • 23. [Quinbolone in the therapy of anemia in uremic patients during periodic hemodialytic treatment].
    Amato M; Bigioli F; Beconi D; Martinelli F; Lapini V; Salvadori M
    Clin Ter; 1980 Jul; 94(1):57-65. PubMed ID: 7438723
    [No Abstract]   [Full Text] [Related]  

  • 24. [Behavior of body weight, blood volume, blood pressure values and heart rate during ultrafiltration and iso-osmotic dialysis].
    Locatelli F; Costanzo R; Di Filippo S; Pedrini L; Marai P; Pozzi C; Ponti R; Sforzini S; Redaelli B
    Minerva Nefrol; 1979; 26(1):91-3. PubMed ID: 471331
    [No Abstract]   [Full Text] [Related]  

  • 25. [Gynecomastia in the uremic patient undergoing periodic hemodialytic treatment].
    Sodi A; Rizzo M; Somigli M
    Minerva Nefrol; 1969; 16(6):420-4. PubMed ID: 5403806
    [No Abstract]   [Full Text] [Related]  

  • 26. [Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy].
    Demelia L; Solinas A; Gogoni G; Marongiu F; Besson A
    Recenti Prog Med; 1982 May; 72(5):664-74. PubMed ID: 6753066
    [No Abstract]   [Full Text] [Related]  

  • 27. [Critical considerations on the neurological manifestations during chronic uremia related to the hemodialytic treatment].
    Barbera G; Rapisarda LM
    Minerva Med; 1970 Nov; 61(90):5134-9. PubMed ID: 5488544
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of factors influencing the hemodynamic and metabolic response to periodic hemodialysis treatment].
    Lojacono L; Butti A; Castagneto M; Cagossi M; Salerni B; Pigliucci GM
    Chir Patol Sper; 1971 Apr; 19(2):120-35. PubMed ID: 5155718
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of the determination of alkaline phosphatase isoenzymes in patients undergoing periodic hemodialytic treatment].
    Stefoni S; Campieri C; Bugiardini R; Biagetti L; Perini L
    Minerva Nefrol; 1979; 26(2):173-6. PubMed ID: 471344
    [No Abstract]   [Full Text] [Related]  

  • 30. [Oxalate behavior in patients undergoing periodic hemodialytic treatments].
    Zucchelli P; Fusaroli M; Sasdelli M; Stallone C
    Minerva Nefrol; 1970; 17(6):184-6. PubMed ID: 5516052
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cholesterol-HDL and apoprotein A in a group of chronic uremic patients undergoing continuing hemodialytic treatment].
    Bergesio F; Ciuti R; Manfredi M; Frizzi V; Zerboni R
    Minerva Nefrol; 1983; 30(3):165-73. PubMed ID: 6646491
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cardiac and circulatory function in uremia].
    Pippig L
    Arch Klin Med; 1968; 214(3):244-72. PubMed ID: 5683860
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radiological evaluation of the state of hydration in uremic patients under periodic dialysis].
    Gavelli G; Zompatori M; Bernasconi A; Baldrati L; Buscaroli A; Orsi C
    Radiol Med; 1984 Dec; 70(12):933-6. PubMed ID: 6545610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anemia of uremia responsive to increased dialysis treatment.
    Lindholm DD; Pace RL; Russell HH
    Trans Am Soc Artif Intern Organs; 1969; 15():360-6. PubMed ID: 5791410
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cimetidine in the therapy of secondary hyperparathyroidism in uremia with hemodialytic treatment].
    Antonucci F; Gropuzzo M; Messa P; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Messa M
    Minerva Nefrol; 1983; 30(3):133-9. PubMed ID: 6646487
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of dietetic integration with essential amino acids in uremic patients treated with long-term hemodialysis].
    Costa A; Rovati C; Degetto P; Midiri R; Valli A; Lo Dico C; Arw K; Frizzi R; Niccolini A; Andreotti C; Comotti C
    Minerva Dietol Gastroenterol; 1981; 27(1):141-5. PubMed ID: 7254597
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of the blood platelets in chronic dialyzed patients before and after hemodialysis. Comparison with a group of patients with grave chronic uremia treated with occasional dialysis].
    Praga C; Brancaccio D; Pogliani E; Della Grazia M
    Minerva Nefrol; 1968; 15(5):322-6. PubMed ID: 5743459
    [No Abstract]   [Full Text] [Related]  

  • 38. [Renal function in chronic uremic patients treated with periodic depuration].
    Casciani C
    Minerva Nefrol; 1967; 14(4):189-92. PubMed ID: 5607560
    [No Abstract]   [Full Text] [Related]  

  • 39. [The visual apparatus in chronic uremia treated with periodic hemodialysis. IV. Exophthalmometric changes during hemodialysis].
    Esposito E; Tufano L; Fortunato G; Sorice PS; Ambrosio A
    Rass Int Clin Ter; 1971 Sep; 51(17):1072-5. PubMed ID: 5132750
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in the content of water, electrolytes, glycogen and protein and nonprotein nitrogen in the skeletal muscle of uremic patients in intermittent hemodialytic treatment].
    Maschio G; Mioni G; Bazzato G; Bruschi E; Guarnieri GF; Blasina B; Bertaglia E
    Minerva Nefrol; 1968; 15(5):331-5. PubMed ID: 5743461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.